breast cancer

Same Survival and Toxicity With APBI and WBI for Breast Cancer

05/04/2016

JCP Editors

Accelerated partial breast irradiation (APBI) leads to the same rates of survival and toxicity as whole breast irradiation (WBI) while also producing significantly better cosmetic results, according to phase 3 trial...

...

05/04/2016

Journal of Clinical Pathways

Breast Conserving Therapy Likely to Result in Recurrence

05/03/2016

JCP Editors

Women younger than 45 years who opt for breast conserving therapy (BCT) over mastectomy may have a higher risk of developing a local recurrence over a 20-year period, according to research presented at European...

Women...

05/03/2016

Journal of Clinical Pathways

Research in Review

Neratinib Delays Recurrence With Fewer Metastases in Patients With Breast Cancer

04/29/2016

JCP Editors

Results from a phase 2 clinical trial showed that combination neratinib and paclitaxel treatment better managed central nervous system progression versus trastuzumab and paclitaxel in patients with ERBB2-positive...

...

04/29/2016

Journal of Clinical Pathways

Genetic Biomarkers Predict Treatment Outcomes for Patients With Breast Cancer

04/25/2016

JCP Editors

Results from a clinical trial presented at the 2016 American Association for Cancer Research Annual Meeting (April 16-20; New Orleans, LA) identified two genetic biomarkers capable of predicting which patients with...

...

04/25/2016

Journal of Clinical Pathways

Research in Review

Human Epidermal Growth Factor Receptor-2 a Strong Indicator of Breast Cancer Prognosis

04/11/2016

JCP Editors

Human epidermal growth factor receptor-2 (HER-2) expression may be a key indicator of recurrence risk in patients with breast cancer, though PIK3CA mutations have no prognostic value, according to a recent...

Human...

04/11/2016

Journal of Clinical Pathways

Research in Review

Wide Variability in Radiation Therapy Following Neoadjuvant Chemotherapy for Patients With Breast Cancer

04/08/2016

JCP Editors

A study conducted by members of the American College of Surgeons has identified a need for greater uniformity and guidelines regarding radiation therapy following neoadjuvant chemotherapy in patients with initial...

A...

04/08/2016

Journal of Clinical Pathways

Research in Review

Novel Breast Cancer Staging System More Effective for Determining Prognosis

03/22/2016

JCP Editors

Researchers at the University of Texas MD Anderson Cancer Center (Houston, TX) have developed a novel staging system that incorporates tumor biology as a critical prognostic indicator for women with breast cancer who...

...

03/22/2016

Journal of Clinical Pathways

Advanced Imaging Overused in Patients With Early-Stage Breast Cancer

03/08/2016

JCP Editors

Norah Lynn Henry, MD, University of Michigan (Ann Arbor, MI), presented findings to suggest that newly diagnosed patients with early-stage breast cancer often undergo advanced imaging tests despite national...

Norah...

03/08/2016

Journal of Clinical Pathways

Clinical Insights

Current Status of Interventional Oncology for Breast Cancer Liver Metastases: Articles From the Official Show Daily for Synergy 2015

03/08/2016

Riad Salem , MD, MBA;

Robert J. Lewandowski , MD, FSIR;

Andrew C. Gordon , BA;

Breast cancer is the most common cancer in women and the second most frequent cause of cancer deaths in women after lung cancer in developed nations.1 Half of patients with metastatic breast cancer (MBC) will be diagnosed with liver...

Breast cancer is the most common...

03/08/2016

IO Learning

Research in Review

Clinical Pathways for Breast, Colon, and Rectal Cancers Improve Physician Adherence to Best Practices

02/16/2016

JCP Editors

Implementation of clinical pathways for breast, colon, and rectal cancers can help narrow the gap between evidence-based treatment guidelines and clinical practice, according to a new study.  With research on...

...

02/16/2016

Journal of Clinical Pathways